Background: The epsilon 4 allele of the apolipoprotein E gene (APOE-epsilon 4) is the stiongest genetic factor for late-onset Alzheimer's disease During middle age, cognitively healthy APOE-epsilon 4 carriers already show several brain alterations that resemble those of Alzheimei's disease (AD), but to a subtler degree. These include microstructural white matter (WM) changes that have been proposed as one of the earliest structural events in the AD cascade. However, previous studies have focused mainly on comparison of APOE-epsilon 4 carriers vs noncarriers. Therefore, the extent and magnitude of the brain alterations in healthy epsilon 4 homozygotes, who are the individuals at highest risk, remain to be chaiacterized in detail. Methods: We...
The human brain\u27s structure can change with age and different health conditions. A genetic risk f...
Apolipoprotein E is a protein involved in cholesterol and lipid transport. The gene coding for this ...
The presence of an ApoE ε4 allele (ε4+) increases the risk of developing Alzheimer's disease (AD). P...
Background: The epsilon 4 allele of the apolipoprotein E gene (APOE-epsilon 4) is the stiongest gene...
Background: The ε4 allele of the apolipoprotein E gene (APOE-ε4) is the strongest genetic factor for...
The ε4 allelic variant of the Apolipoprotein E gene (APOE ε4) is the best-established genetic risk f...
The Apolipoprotein E (APOE) ɛ4 allele is the best-established genetic risk factor for sporadic Alzhe...
Alzheimer's disease (AD) is a neurodegenerative disorder that causes atrophy in gray and white matte...
The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous w...
The apolipoprotein E epsilon4 allele is a well established genetic risk factor for sporadic Alzheime...
The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous w...
Alzheimer’s disease (AD) is the most common form of dementia and the leading risk factor, after age,...
AbstractIntroductionLittle is still known about the effects of risk factors for Alzheimer's disease ...
Previous studies have consistently suggested that the epsilon 4 allele of apolipoprotein E (APOE) ge...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Re...
The human brain\u27s structure can change with age and different health conditions. A genetic risk f...
Apolipoprotein E is a protein involved in cholesterol and lipid transport. The gene coding for this ...
The presence of an ApoE ε4 allele (ε4+) increases the risk of developing Alzheimer's disease (AD). P...
Background: The epsilon 4 allele of the apolipoprotein E gene (APOE-epsilon 4) is the stiongest gene...
Background: The ε4 allele of the apolipoprotein E gene (APOE-ε4) is the strongest genetic factor for...
The ε4 allelic variant of the Apolipoprotein E gene (APOE ε4) is the best-established genetic risk f...
The Apolipoprotein E (APOE) ɛ4 allele is the best-established genetic risk factor for sporadic Alzhe...
Alzheimer's disease (AD) is a neurodegenerative disorder that causes atrophy in gray and white matte...
The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous w...
The apolipoprotein E epsilon4 allele is a well established genetic risk factor for sporadic Alzheime...
The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer's disease (AD). Previous w...
Alzheimer’s disease (AD) is the most common form of dementia and the leading risk factor, after age,...
AbstractIntroductionLittle is still known about the effects of risk factors for Alzheimer's disease ...
Previous studies have consistently suggested that the epsilon 4 allele of apolipoprotein E (APOE) ge...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Re...
The human brain\u27s structure can change with age and different health conditions. A genetic risk f...
Apolipoprotein E is a protein involved in cholesterol and lipid transport. The gene coding for this ...
The presence of an ApoE ε4 allele (ε4+) increases the risk of developing Alzheimer's disease (AD). P...